SCHEMBL2961584

SCHEMBL2961584

COc1cc(O)c2c(c1)OC(c1ccc(O)c(O)c1)CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 6/20 0.54
CLK2 P49760 1/20 0.53
EPHX2 P34913 1/20 0.53
ALDH1A1 P00352 4/20 0.47
MAPT P10636 4/20 0.47
ADORA3 P0DMS8 2/20 0.47
TDP1 Q9NUW8 2/20 0.47
ATM Q13315 2/20 0.47
TAS2R31 P59538 1/20 0.47
ABCG2 Q9UNQ0 1/20 0.44
BACE1 P56817 4/20 0.42
KDM4E B2RXH2 3/20 0.42
PKM P14618 3/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP3A4 P08684 3/20 0.42
MEN1 O00255 2/20 0.42
GAA P10253 2/20 0.42
KMT2A Q03164 2/20 0.42
APEX1 P27695 2/20 0.42
RECQL P46063 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31053988 1.00 CYP19A1 (0.54) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL2970150 0.90 CYP19A1 (0.56) CYP19A1CLK2EPHX2ALDH1A1MAPT
(2S)-3',4'-Dihydroxy-5,7-Dimethoxyflavan SCHEMBL2968482 0.90 CYP19A1 (0.52) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL31053922 0.88 CYP19A1 (0.50) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL29066388 0.86 ABCG2 (0.59) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL30468829 0.85 KDM4E (0.57) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL18427306 0.85 KDM4E (0.57) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL8243518 0.85 KDM4E (0.57) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL2595124 0.85 KDM4E (0.57) CYP19A1CLK2EPHX2ALDH1A1MAPT
SCHEMBL8247927 0.85 KDM4E (0.57) CYP19A1CLK2EPHX2ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2253226-B1 Use of hydroxyflavone derivatives for modifying taste LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) 2015-07-15 EP claimed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP claimed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US claimed
EP-2633886-B1 COMPOUNDS AND MIXTURES INFLUENCING INFLAMMATORY STATES SYMRISE AG (DE) 2018-01-31 EP disclosed
EP-2253226-B1 Use of hydroxyflavone derivatives for modifying taste LEIBNIZ INST FÜR PFLANZENBIOCHEMIE IPB (DE) 2015-07-15 EP disclosed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP disclosed
EP-2253226-A1 Use of hydroxyflavone derivatives for modifying taste Leibniz-Institut für Pflanzenbiochemie (IPB) (DE) 2010-11-24 EP disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION Leibniz-Institut fur Pflanzenbiochemie (DE) 2010-11-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292175-A1 USE OF HYDROXYFLAVAN DERIVATIVES FOR TASTE MODIFICATION TAS2R50, TAS2R60, TAS2R30 CYP19A1 3419/4885CLK2 2862/4885EPHX2 3666/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.